Nasdaq rates NVO stock highest based on Warren Buffett's strategy, with strong fundamentals and valuation.

From Nasdaq: 2025-06-18 14:06:00

Validea’s guru fundamental report for NOVO NORDISK A/S (ADR) (NVO) shows the stock rates highest using the Patient Investor model based on Warren Buffett’s strategy. NVO is a large-cap growth stock in the Biotechnology & Drugs industry with a rating of 100% based on strong fundamentals and valuation. The stock meets the criteria for earnings predictability, debt service, return on equity, return on total capital, free cash flow, use of retained earnings, share repurchase, initial rate of return, and expected return. Warren Buffett is known for his successful investing strategies and modest lifestyle. Validea is an investment research service that follows the strategies of investment legends.



Read more at Nasdaq: NVO Factor-Based Stock Analysis – Warren Buffett